News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,432 Results
Type
Article (27720)
Company Profile (114)
Press Release (384594)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (102281)
Career Advice (545)
Deals (18043)
Drug Delivery (91)
Drug Development (38943)
Employer Resources (80)
FDA (10902)
Job Trends (10027)
News (176080)
Policy (20866)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2122)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (92)
Alliances (28683)
ALS (87)
Alzheimer's disease (1108)
Antibody-drug conjugate (ADC) (149)
Approvals (11213)
Artificial intelligence (360)
Autoimmune disease (81)
Automation (20)
Bankruptcy (148)
Best Places to Work (9003)
BIOSECURE Act (8)
Biosimilars (156)
Biotechnology (57)
Bladder cancer (103)
Brain cancer (35)
Breast cancer (357)
Cancer (2542)
Cardiovascular disease (288)
Career advice (508)
Career pathing (14)
CAR-T (115)
CDC (51)
Cell therapy (362)
Cervical cancer (26)
Clinical research (34090)
Collaboration (1048)
Compensation (147)
Complete response letters (22)
COVID-19 (2303)
CRISPR (52)
C-suite (496)
Cystic fibrosis (88)
Data (3740)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (339)
Diagnostics (5157)
Digital health (45)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (136)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (125)
Earnings (36222)
Editorial (40)
Employer branding (8)
Employer resources (72)
Events (76225)
Executive appointments (656)
FDA (13062)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (4)
Frontotemporal dementia (15)
Funding (1033)
Gene editing (99)
Generative AI (34)
Gene therapy (286)
GLP-1 (591)
Government (4387)
Grass and pollen (6)
Guidances (284)
Healthcare (15086)
HIV (52)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (111)
Immuno-oncology (28)
Indications (72)
Infectious disease (2545)
Inflammatory bowel disease (124)
Inflation Reduction Act (16)
Influenza (108)
Intellectual property (114)
Interviews (59)
IPO (7785)
IRA (40)
Job creations (1412)
Job search strategy (450)
JPM (60)
Kidney cancer (4)
Labor market (39)
Layoffs (212)
Leadership (11)
Legal (3938)
Liver cancer (57)
Longevity (12)
Lung cancer (312)
Lymphoma (202)
Machine learning (20)
Management (30)
Manufacturing (404)
MASH (106)
Medical device (9626)
Medtech (9670)
Mergers & acquisitions (10931)
Metabolic disorders (845)
Multiple sclerosis (110)
NASH (10)
Neurodegenerative disease (184)
Neuropsychiatric disorders (61)
Neuroscience (1881)
Neurotech (1)
NextGen: Class of 2026 (4993)
Non-profit (3948)
Now hiring (13)
Obesity (389)
Opinion (158)
Ovarian cancer (79)
Pain (110)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (21)
Patents (219)
Patient recruitment (278)
Peanut (32)
People (33682)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10801)
Phase 2 (13389)
Phase 3 (12126)
Pipeline (3311)
Policy (241)
Postmarket research (1574)
Preclinical (3463)
Press Release (47)
Prostate cancer (143)
Psychedelics (38)
Radiopharmaceuticals (169)
Rare diseases (530)
Real estate (2875)
Recruiting (32)
Regulatory (15584)
Reports (25)
Research institute (1964)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (161)
Series B (132)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2116)
Stomach cancer (4)
Supply chain (71)
Tariffs (47)
The Weekly (44)
Vaccines (845)
Venture capital (67)
Weight loss (237)
Women's health (82)
Worklife (7)
Date
Last 7 days (345)
Last 30 days (1339)
Last 365 days (18629)
2026 (1872)
2025 (19043)
2024 (21774)
2023 (24258)
2022 (33688)
2021 (37127)
2020 (37571)
2019 (33251)
2018 (24876)
2017 (17709)
2016 (18859)
2015 (21431)
2014 (16062)
2013 (12726)
2012 (13468)
2011 (13910)
2010 (11931)
Location
Africa (531)
Alabama (35)
Alaska (6)
Arizona (183)
Arkansas (11)
Asia (22421)
Australia (3970)
California (6195)
Canada (2174)
China (609)
Colorado (305)
Connecticut (333)
Delaware (191)
Europe (50416)
Florida (985)
Georgia (262)
Hawaii (2)
Idaho (39)
Illinois (598)
India (54)
Indiana (450)
Iowa (13)
Japan (292)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (948)
Massachusetts (4583)
Michigan (219)
Minnesota (400)
Mississippi (3)
Missouri (119)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (59)
New Jersey (2157)
New Mexico (12)
New York (1944)
North Carolina (962)
North Dakota (4)
Northern California (3094)
Ohio (217)
Oklahoma (13)
Oregon (28)
Pennsylvania (1431)
Puerto Rico (12)
Rhode Island (29)
South America (681)
South Carolina (34)
South Dakota (1)
Southern California (2345)
Tennessee (138)
Texas (940)
United States (24453)
Utah (265)
Virginia (143)
Washington D.C. (53)
Washington State (601)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
412,432 Results for "puretech health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
2 min read
Press Releases
PureTech Health plc – Half-Year Report 2025
August 28, 2025
·
19 min read
Press Releases
PureTech Appoints Robert Lyne as Chief Executive Officer
December 18, 2025
·
5 min read
Press Releases
PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
December 8, 2025
·
10 min read
Press Releases
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
December 8, 2025
·
9 min read
Press Releases
PureTech’s Founded Entity Gallop Oncology to Present New Data from Ongoing Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia (AML) at the American Society of Hematology (ASH) Annual Meeting
November 3, 2025
·
9 min read
Press Releases
PureTech Announces Board Change
July 9, 2025
·
4 min read
Genetown
PureTech Health: Results of the Tender Offer - June 24, 2024
PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, announces the results of the Tender Offer, as set out in the Shareholder circular published by the Company on 20 May 2024.
June 24, 2024
·
10 min read
Genetown
PureTech Health: Result of General Meeting
PureTech Health plc is pleased to announce that at the General Meeting of the Company held at 11:00 a.m. New York City time at the Company’s offices at 6 Tide Street, Boston, Massachusetts, 02210, United States, the proposed Special Resolution as set out in the Circular containing the Notice of General Meeting circulated to Shareholders and published on 20 May 2024 was duly passed.
June 6, 2024
·
5 min read
Press Releases
PureTech to Present at the Jefferies Global Healthcare Conference
May 22, 2025
·
2 min read
1 of 41,244
Next
